News

Find News

Filter articles

Applied Filters

Showing 31 to 40 of 128 results

Takeda makes fourth offer to buy Shire

Ireland, Japan23-04-2018

Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

China releases measures to boost pharma IP protection

China18-04-2018

China’s government has announced a series of measures to increase the country’s importation of drugs, including enhanced IP protection in the pharmaceutical industry.

China to slash tax for generic makers to 15%

China09-04-2018

China’s government has announced plans to implement preferential tax rates to generic drug makers in a bid to encourage the manufacturing of generics. 

Fujifilm makes $800m acquisition

Japan05-04-2018

Japan-based Fujifilm has revealed its plan to acquire two cell culture media companies for $800 million.  

Eisai unites with Nichi-Iko to boost generics business

Japan03-04-2018

Eisai has partnered with fellow Japanese pharmaceutical company Nichi-Iko Pharmaceutical to expand and grow Nichi-Iko’s generic business.

Takeda mulls Shire acquisition bid

Ireland, Japan03-04-2018

Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.

Eisai partners with Merck for cancer drug R&D

China, US09-03-2018

Japanese pharmaceutical company Eisai has teamed up with US-based Merck in a deal intended to strengthen the worldwide development and commercialisation of cancer drug Lenvima.

UK agrees £500m of life sciences deals in China

China, UK21-02-2018

More than £500 million worth of life sciences and healthcare agreements were signed between the UK and China during the UK Prime Minister’s visit to China earlier this month.

Allergan to buy Australian tissue repair company for $95m

Australia, Ireland12-02-2018

Allergan is set to acquire Australia-based Elastagen, a clinical-stage company focused on developing medical device products based on recombinant tropoelastin, for $95 million.

AstraZeneca forms health tech partnerships in China

China06-02-2018

AstraZeneca has announced partnerships with Chinese companies Alibaba and Tencent, in agreements that will use emerging technologies to improve healthcare in China.

Showing 31 to 40 of 128 results

LSIPR